Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial

被引：0
|
作者：
Estes, N. A. Mark, III [1 ]
机构：
[1] Tufts Univ, Sch Med, New England Cardiac Arrhythmia Ctr, Div Cardiol,Dept Med, Boston, MA 02111 USA
来源：
HEART RHYTHM | 2008年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [31] Impact of study design on recruitment of patients to a primary care trial: an observational time series analysis of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) Study
    Fletcher, K.
    Mant, J.
    Roalfe, A.
    Hobbs, F. D. R.
    FAMILY PRACTICE, 2010, 27 (06) : 691 - 697
  • [32] Warfarin vs aspirin for prevention of stroke in nonvalvular atrial fibrillation: Meta-analysis
    Benavente, O
    Hart, RG
    STROKE, 1999, 30 (01) : 241 - 241
  • [33] Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation - Japan atrial fibrillation stroke trial
    Sato, H
    Ishikawa, K
    Kitabatake, A
    Ogawa, S
    Maruyama, Y
    Yokota, Y
    Fukuyama, T
    Doi, Y
    Mochizuki, S
    Izumi, T
    Takekoshi, N
    Yoshida, K
    Hiramori, K
    Origasa, H
    Uchiyama, S
    Matsumoto, M
    Yamaguchi, T
    Hori, M
    STROKE, 2006, 37 (02) : 447 - 451
  • [34] Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation
    Hart, Robert G.
    Pearce, Lesly A.
    Aguilar, Maria I.
    ANNALS OF INTERNAL MEDICINE, 2007, 147 (08) : 590 - 592
  • [35] Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation
    Miller, VT
    Pearce, LA
    Feinberg, WM
    Rothrock, JF
    Anderson, DC
    Hart, RG
    NEUROLOGY, 1996, 46 (01) : 238 - 240
  • [36] Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial
    Shoamanesh, Ashkan
    Field, Thalia S.
    Coutts, Shelagh B.
    Sharma, Mukul
    Gladstone, David
    Hart, Robert G.
    Boriani, Giuseppe
    Wright, David J.
    Sticherling, Christian
    Birnie, David H.
    Gold, Michael R.
    Erath, Julia W.
    Kutyifa, Valentina
    Mian, Rajibul
    Benz, Alexander P.
    Granger, Christopher B.
    Mcintyre, William F.
    Connolly, Stuart J.
    Nielsen, Jens Cosedis
    Alings, Marco
    Rivard, Lena
    Lopes, Renato
    Healey, Jeff S.
    LANCET NEUROLOGY, 2025, 24 (01): : 140 - 151
  • [37] Warfarin, Aspirin, and Their Combination in the Prevention of Stroke in Patients With Atrial Fibrillation: A Nested Case-control Study
    Azoulay, Laurent
    Renoux, Christel
    Simon, Teresa
    DellAniello, Sophie
    Suissa, Samy
    STROKE, 2010, 41 (04) : E215 - E216
  • [38] Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation
    Edvardsson, N
    Juul-Möller, S
    Ömblus, R
    Pehrsson, K
    JOURNAL OF INTERNAL MEDICINE, 2003, 254 (01) : 95 - 101
  • [39] Cost-effectiveness of warfarin: Trial versus "real-world" stroke prevention in atrial fibrillation
    Sorensen, Sonja V.
    Dewilde, Sarah
    Singer, Daniel E.
    Goldhaber, Samuel Z.
    Monz, Brigitta U.
    Plumb, Jonathan M.
    AMERICAN HEART JOURNAL, 2009, 157 (06) : 1064 - 1073
  • [40] A Cost Benefit Analysis of Left Atrial Appendage Closure versus Warfarin for Stroke Prevention in Atrial Fibrillation
    Reddy, Vivek
    Amorosi, Stacey L.
    Armstrong, Shannon
    Garfield, Susan S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B31 - B31
12345